ABIO 05/01 regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation to Abiogen's ABIO 05/01 to treat peritoneal carcinosis caused by ovarian cancer. The cy...